These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16598296)

  • 1. A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin.
    Benjamin DK; Schelonka R; White R; Holley HP; Bifano E; Cummings J; Adcock K; Kaufman D; Puppala B; Riedel P; Hall B; White J; Cotton CM;
    J Perinatol; 2006 May; 26(5):290-5. PubMed ID: 16598296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates.
    Baker CJ; Melish ME; Hall RT; Casto DT; Vasan U; Givner LB
    N Engl J Med; 1992 Jul; 327(4):213-9. PubMed ID: 1614462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients.
    Fattom A; Fuller S; Propst M; Winston S; Muenz L; He D; Naso R; Horwith G
    Vaccine; 2004 Dec; 23(5):656-63. PubMed ID: 15542186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia.
    Rupp ME; Holley HP; Lutz J; Dicpinigaitis PV; Woods CW; Levine DP; Veney N; Fowler VG
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4249-54. PubMed ID: 17893153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants.
    DeJonge M; Burchfield D; Bloom B; Duenas M; Walker W; Polak M; Jung E; Millard D; Schelonka R; Eyal F; Morris A; Kapik B; Roberson D; Kesler K; Patti J; Hetherington S
    J Pediatr; 2007 Sep; 151(3):260-5, 265.e1. PubMed ID: 17719934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G.
    Sandberg K; Fasth A; Berger A; Eibl M; Isacson K; Lischka A; Pollak A; Tessin I; Thiringer K
    J Pediatr; 2000 Nov; 137(5):623-8. PubMed ID: 11060526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
    Fanaroff AA; Korones SB; Wright LL; Wright EC; Poland RL; Bauer CB; Tyson JE; Philips JB; Edwards W; Lucey JF
    N Engl J Med; 1994 Apr; 330(16):1107-13. PubMed ID: 8133853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled investigation of the safety of intravenous immune globulin administration to preterm neonates.
    Christensen RD; Hardman T; Thornton J; Hill HR
    J Perinatol; 1989 Jun; 9(2):126-30. PubMed ID: 2738720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short antibiotic prophylaxis for bacterial infections in a neonatal intensive care unit: a randomized controlled trial.
    Auriti C; Ravà L; Di Ciommo V; Ronchetti MP; Orzalesi M
    J Hosp Infect; 2005 Apr; 59(4):292-8. PubMed ID: 15749316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units.
    Huang YC; Chou YH; Su LH; Lien RI; Lin TY
    Pediatrics; 2006 Aug; 118(2):469-74. PubMed ID: 16882797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis.
    Weisman LE; Thackray HM; Steinhorn RH; Walsh WF; Lassiter HA; Dhanireddy R; Brozanski BS; Palmer KG; Trautman MS; Escobedo M; Meissner HC; Sasidharan P; Fretz J; Kokai-Kun JF; Kramer WG; Fischer GW; Mond JJ
    Pediatrics; 2011 Aug; 128(2):271-9. PubMed ID: 21788224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal and postnatal prophylaxis of infections in preterm neonates.
    von Muralt G; Sidiropoulos D
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S72-8. PubMed ID: 3135529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines.
    Robbins JB; Schneerson R; Horwith G; Naso R; Fattom A
    Am Heart J; 2004 Apr; 147(4):593-8. PubMed ID: 15077073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Staphylococcus aureus infections: advances in vaccine development.
    Shinefield HR; Black S
    Expert Rev Vaccines; 2005 Oct; 4(5):669-76. PubMed ID: 16221068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of 7-Day vs. 14-Day antibiotics for neonatal sepsis.
    Chowdhary G; Dutta S; Narang A
    J Trop Pediatr; 2006 Dec; 52(6):427-32. PubMed ID: 17030532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin therapy for prevention of infection in high-risk premature infants: report of a multicenter, double-blind study.
    Magny JF; Bremard-Oury C; Brault D; Menguy C; Voyer M; Landais P; Dehan M; Gabilan JC
    Pediatrics; 1991 Sep; 88(3):437-43. PubMed ID: 1881720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants.
    Bloom B; Schelonka R; Kueser T; Walker W; Jung E; Kaufman D; Kesler K; Roberson D; Patti J; Hetherington S;
    Pediatr Infect Dis J; 2005 Oct; 24(10):858-66. PubMed ID: 16220082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven-year experience with a surveillance program to reduce methicillin-resistant Staphylococcus aureus colonization in a neonatal intensive care unit.
    Gregory ML; Eichenwald EC; Puopolo KM
    Pediatrics; 2009 May; 123(5):e790-6. PubMed ID: 19403471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes in methicillin-resistant Staphylococcus aureus-colonized neonates in the neonatal intensive care unit.
    Kim YH; Chang SS; Kim YS; Kim EA; Yun SC; Kim KS; Pi SY
    Neonatology; 2007; 91(4):241-7. PubMed ID: 17568155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia.
    Kuhn P; Messer J; Paupe A; Espagne S; Kacet N; Mouchnino G; Klosowski S; Krim G; Lescure S; Le Bouedec S; Meyer P; Astruc D
    J Pediatr; 2009 Sep; 155(3):324-30.e1. PubMed ID: 19467544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.